Form 4 Tracker
David Malcom Rodman

Chief Medical Officer · 11 filings · Latest: Apr 17, 2026

Mineralys Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MLYS
Rodman David MalcomMay 13, 2026
Proposed Sale
$28.5814,056$401.8K
MLYS
Rodman David MalcomMay 12, 2026
Proposed Sale
$29.366,348$186.3K
MLYS
Rodman David MalcomMay 11, 2026
Proposed Sale
$29.712,171$64.5K
MLYS
David Malcom RodmanChief Medical OfficerApr 17, 2026
Sale
$31.33416$13.0K69,792
MLYS
David Malcom RodmanChief Medical OfficerApr 17, 2026
Option Exercise
$15.44416$6.4K70,208
MLYS
Rodman David MalcomApr 17, 2026
Proposed Sale
$31.33416$13.0K
MLYS
David Malcom RodmanChief Medical OfficerApr 15, 2026
Sale
$27.666,348$175.6K69,792
MLYS
David Malcom RodmanChief Medical OfficerApr 13, 2026
Sale
$26.5414,058$373.1K76,140
MLYS
David Malcom RodmanChief Medical OfficerApr 13, 2026
Option Exercise
$7.2814,058$102.4K90,198
MLYS
Rodman David MalcomApr 15, 2026
Proposed Sale
$27.666,348$175.6K
MLYS
David Malcom RodmanChief Medical OfficerApr 9, 2026
Sale
$27.382,170$59.4K76,140
MLYS
David Malcom RodmanChief Medical OfficerApr 9, 2026
Option Exercise
$16.002,170$34.7K78,310
MLYS
Rodman David MalcomApr 13, 2026
Proposed Sale
$26.5414,058$373.1K
MLYS
Rodman David MalcomApr 9, 2026
Proposed Sale
$27.382,170$59.4K
MLYS
Rodman David MalcomMar 17, 2026
Proposed Sale
$25.65417$10.7K
MLYS
David Malcom RodmanChief Medical OfficerMar 17, 2026
Sale
$25.65417$10.7K76,140
MLYS
David Malcom RodmanChief Medical OfficerMar 17, 2026
Option Exercise
$15.44417$6.4K76,557
MLYS
David Malcom RodmanChief Medical OfficerMar 13, 2026
Sale
$26.2614,058$369.2K76,140
MLYS
David Malcom RodmanChief Medical OfficerMar 13, 2026
Option Exercise
$12.397,709$95.5K90,198
MLYS
David Malcom RodmanChief Medical OfficerMar 12, 2026
Sale
$27.376,348$173.7K82,489

Page 1 of 3

Next →